The study, published in Clinical and Experimental Medicine, analyzed blood samples from 18 patients with SLE and 21 healthy controls to identify distinct alterations in innate and humoral immunity. By evaluating granulocytes, B cells, T lymphocytes, and regulatory cells, the team identified a unique immune signature associated with the disease. The AI model achieved a precision, recall, and area under the curve (AUC) of 1.00, indicating a perfect separation between the two groups in this specific cohort.
The central finding of the research is that patients with SLE exhibit a distinct pattern of immune cell changes that reflects an active primary humoral response. Specifically, the study observed increased levels of effector memory and terminal effector CD4+ T cells, marginal zone B cells, and IgMhi B cells in the SLE group. Conversely, the patients showed decreased levels of memory, follicular, and IgMdim B cells. These shifts suggest that the disease is characterized by a specific imbalance in the humoral immune system, where certain B cell subsets are expanded while others are reduced.
The study utilized an artificial intelligence model to evaluate the predictive role of each immune cell subset in distinguishing between SLE patients and healthy controls. The model identified five key predictive subsets that were critical for its classification accuracy. These included follicular, IgMhi, and IgMdim B cells; CTLA4+PD-1+ cells within FoxP3+ CD4+ Treg cells; and effector memory CD8+ αβ T cells. By isolating these specific subsets, the researchers were able to demonstrate that the combination of these markers provides a robust signature for SLE.
The sample size for this study was relatively small, consisting of 18 SLE patients and 21 healthy controls. While the AI model showed perfect discrimination in this cohort, the limited number of participants is a notable limitation. The study was designed to assess immune cell profile changes and evaluate the role of specific subsets in group distinction. The analysis covered a broad range of immune cells, including granulocytes and various lymphocyte populations. The results indicate that the identified immune cell profile is distinct in SLE patients, enhancing the understanding of immune dynamics in the disease. However, the generalizability of these findings to a larger, more diverse population remains to be determined in future studies.
The research contributes to the broader understanding of SLE pathogenesis by linking specific immune cell alterations to the disease state. The identification of an active primary humoral response through the observed B cell changes provides a mechanistic insight into the disease.
By focusing on specific immune cell subsets, the researchers were able to create a model with high predictive accuracy. The distinct immune cell profile identified in SLE patients offers a new perspective on the disease’s immunological landscape. Future research will need to validate these findings in larger cohorts to confirm the robustness of the AI model.
Subject of Research: Artificial intelligence characterization of immune cell profiles in systemic lupus erythematosus
Article Title: Characterization of immune cell profiles of innate and humoral immunity in patients with systemic lupus erythematosus through artificial intelligence
Article References: Li, P.-Y., Tsao, Y.-P., Sun, Y.-S., Tsai, H.-C., Lee, C.-Y., Chan, C.-W., Chu, Y.-Y., Chen, Y.-H., Lin, S.-R., Wang, S.-L., Lai, W.-Y., Lee, J.-M., & Chen, M.-H. (2026). Characterization of immune cell profiles of innate and humoral immunity in patients with systemic lupus erythematosus through artificial intelligence. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-026-02369-z
Image Credits: AI Generated
DOI: 10.1007/s10238-026-02369-z
Keywords: systemic lupus erythematosus, artificial intelligence, immune cell profiles, humoral immunity, innate immunity, B cells, T lymphocytes, autoimmune disease, diagnostic model, clinical research, Characterization, immune
News Source: Ophelia Keating. (November 8, 2026). AI Model Distinguishes SLE Immune Profiles from Healthy Controls. Scienmag.



